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Background: The present randomized double-blind multicenter study was designed to assess the efficacy of a progressive
compressive stocking (new concept with maximal pressure at calf), compared to a degressive compressive stocking graded
30 mm Hg, evaluating the improvement of lower leg symptoms of chronic venous insufficiency (CVI) in ambulatory
patients with moderate to severe chronic venous disease.
Methods: Both gender outpatients presenting symptomatic moderate to severe CVI were eligible for a treatment by
compressive stockings. Patients were randomly assigned to receive either degressive compressive stockings (30 mm Hg at
ankle, 21 mm Hg at upper calf) or progressive compressive stockings (10 mm Hg at ankle, 23 mm Hg at upper calf). The
primary outcome, evaluated after 3 months, was a composite success outcome, including improvement of pain or heavy
legs without onset of either ulcer, deep or superficial vein thrombosis of the lower limbs, or pulmonary embolism. The
ease of application of the compressive stockings reported by patients was one of secondary outcome.
Results: Overall, 401 patients (199 in the progressive compressive stocking group and 202 in the degressive compressive
stocking group) were randomized by 44 angiologists in France. Among them, 66% were classified in the C3 CEAP
category. The rate of success was significantly higher in the progressive compressive stocking group compared to the
degressive compressive stocking group (70.0% vs 59.6%; relative risk, 1.18; 95% confidence interval, 1.02-1.37; P .03).
This was mainly due to more frequent symptom improvement in the progressive compressive stocking group. The
compressive stockings were considered easy to apply by 81.3% of patients in the progressive compressive stocking group
vs 49.7% of patients in the degressive compressive stocking group (P < .0001). The rate of related serious adverse events
was low and similar in both groups.
Conclusions: This trial has demonstrated that progressive compressive stockings are more effective than usual degressive
compressive stockings in the improvement of pain and lower leg symptoms in patients with CVI. Moreover, progressive
compressive stockings were easier to apply, raising no safety concern at 3 months. (J Vasc Surg 2012;56:1344-50.)
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(CVI) have an important clinical and economic impact as
they may affect 15% to 33% of the general population,1,2
and their prevalence increases with age.
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1344Compression stockings are themainstay of conservative
reatment in CVI.
Graded degressive compressive stockings have been
sed for many decades and are characterized by a high
ressure applied at the ankle and a decreasing pressure from
he ankle to the knee.
Treatment with degressive compressive stockings ap-
lying high pressure from 30 to 40 mm Hg at the ankle
esults in significant improvement in pain, swelling, activity,
nd well-being if high compliance is achieved.3 Even
hough there are low levels of evidence evaluating mainly
ain and swelling,4 this treatment is recommended in all
EAP classes.5
Unfortunately, these high ankle pressures are associ-
ted with low compliance and inability to apply the
ompressive stockings, especially in elderly people.6 We
ypothesized that the use of progressive compressive
tockings applying the highest pressure on the calf would
etter decrease the symptoms of CVI by the improve-
ent of calf muscle pump in ambulatory patients and,
hus, facilitate the use of the garment by lowering the
ressure at the ankle.7
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Volume 56, Number 5 Couzan et al 1345The present study was designed to assess the efficacy of
progressive (calf) compressive stockings compared to a
degressive compressive stocking graded 30 mm Hg in the
improvement of lower leg symptoms of CVI in ambulatory
patients with moderate to severe chronic venous disease as
defined by the CEAP classification.8
METHODS
Patients. Patients were enrolled in a national, multi-
center, double-blind, randomized controlled trial. They
were male or female adult outpatients, presenting current
pain and/or heavy legs due to moderate to severe CVI
(CEAP C2b to C5) and eligible for a 30-mmHg compres-
sive therapy. The exclusion criteria were bandage therapy
recommended, current use of a compressive stocking 30
mm Hg, active ulcer, deep vein thrombosis or pulmonary
embolism in the past 3 months, arterial disease of the lower
limb, nonvenous edema, inflammatory, dermatologic, or
traumatic disorder of a lower limb, known hypersensitivity
to components of the study compressive stockings, surgery
or vascular procedure in the past month or planned in the
next 3 months, poor life expectancy, inability to walk, and
pregnancy.
All patients received information about the study and
gave their written informed consent to participate before
inclusion. The study protocol was approved by the local
ethics committee and by French health authorities.
Procedures. After screening for eligibility and physical
examination, the investigator entered patient identification
and lower limb measurements via a web or telephone
server. Randomization was performed by computer, pre-
ceded to either knee-length upward progressive compres-
sive stockings (10 mm Hg at the ankle, 23 mm Hg at the
upper calf) or degressive compressive stockings (30mmHg
at the ankle, 21 mm Hg at the upper calf).
Degressive and progressive compressive stockings were
identical in appearance, made with the same material, and
prepared by the same manufacturer (Lempy Medical, Rou-
baix, France), in agreement with all national and European
applicable standards. To insure the blinding, lower limb
measurements were automatically sent to the logistic center
of treatment distribution that was in charge of preparing
the treatment and sent them directly to the patients using
pre-stamped envelopes. Finally, patients were instructed
not to bring their compressive stockings to the evaluation
visit. Neither the patient nor the investigator was informed
of the assigned group.
Patients were otherwise instructed to wear the com-
pressive stockings daily, from morning to bedtime, during
6 months. The follow-up included a visit at baseline and at
month 3 and a phone call at months 1 and 6, performed by
either the investigator or the study coordinating center,
depending on the investigator’s choice.
Outcomes. The primary outcome, evaluated after 3
months of treatment, was composite and defined as an
improvement of pain or heavy legs without onset of either
ulcer, deep or superficial vein thrombosis of the lower limb,
or pulmonary embolism. The improvements of pain and meavy legs were evaluated using the combination of two
our-level scores with the following categories: disappear-
nce, important amelioration, slight amelioration, and lack
f amelioration. The improvement was defined as the dis-
ppearance or an important amelioration in at least one
riterion without a lack of amelioration in the other. Sec-
ndary outcomes were the above composite outcome at
onths 1 and 6, as well as each component of the compos-
te outcome at month 3, compliance, ease of application,
nd discomfort/harm related to the compressive stockings
t months 1, 3, and 6. Moreover, patients were interviewed
oncerning eventual venous or adverse events, compliance,
asiness to apply, and discomfort/harm related to the
tockings. At month 3, a physical examination was per-
ormed and CEAP and modified Venous Clinical Severity
core (VCSS)9 were evaluated.
Statistical analysis. Based on a previous study with
rogressive compressive stockings in mild venous insuffi-
iency, we estimated an increase in the rate of success by
7% (relative risk [RR], 1.17; success rate of 62% in the
egressive compressive group).10 In a population of more
evere patients, we believed the success rate would be
ower, especially when adding the foreseen few additional
ercentage of patients who would have a venous thrombo-
mbolism. Thus, we expected a success rate of 50% in the
egressive compressive group, and the study was designed
o evidence an RR of 1.28 between groups. With 80%
ower, using a two-tailed test at the 0.05 threshold, 192
atients per group were required, and it was decided to
ecruit 400 patients overall.
The composite primary outcome was compared be-
ween groups using the Fisher exact test. Where symptoms
ere unknown at month 3 but known at months 1 and 6,
issing values were replaced by the worst observed value.
n RR along with its 95% confidence interval (CI) was also
omputed. Other assessed items were compared using the
isher exact test or the t-test, as appropriate. Analysis was
erformed by intent-to-treat.
A meta-analysis was performed on individual patient
ata from a previous randomized double-blind controlled
rial of progressive compressive stockings in patients with
ild venous insufficiency9 and those reported here. The
No track of  patients screened for eligibility was recorded. 
401 included and randomised
199 assigned to progressive 
compressive stockings 
202 assigned to degressive 
compressive stockings 
4 lost to follow-up 
7 no assessment of  
primary outcome 
5 lost to follow-up 
4 no assessment of  
primary outcome 
188 analysed for the 
primary outcome 
193 analysed for the 
primary outcome 
Fig 1. Trial profile.eta-analysis was performed using the logarithm of the RR
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November 20121346 Couzan et alusing the EasyMA software.11,12 Association and heteroge-
neity tests were performed for each comparison. In case of
heterogeneity, a random-effect model for the RR was used.
RESULTS
Description of population. Overall, 401 patients en-
rolled by 44 angiologists throughout France were included
between June 2007 and March 2008: 199 in the progres-
sive compressive stocking group and 202 in the degressive
compressive stocking group. The data of 381 patients were
available for the analysis of the primary outcome (Fig 1).
The other analyses were performed on all patients with
nonmissing data.
As shown in Table I, patients from both groups were
similar at baseline. Two-thirds of patients had a C3-grade
venous insufficiency and most of them had numerous or
extended varicose veins. Their VCSS ranged from 3 to 10
with a median of 5. Two hundred forty patients (61.2%)
had prior varicose veins treatment and 93 patients (23.7%)
had experienced one or more thromboembolic events pre-
viously.
Primary efficacy outcome. At month 3, the rate of
Table I. Demographic and clinical characteristics
Age, years
Men
Obesity (BMI 30 kg/m2)
CEAP clinical score
C2b: varicose veins (3-mm diameter)
C3: edema
C4a: pigmentation or eczema
C4b: lipodermatosclerosis or atrophy
blanche
C5: healed venous ulcer
VCSSa
Presence of edema
In the evening, limited to the ankle
In the afternoon, reaching above the ankle
From the morning, requiring limb raising
History of VTE
Superficial vein thrombosis
Deep vein thrombosis
Pulmonary embolism
Past varicose vein treatment
Surgery
Endovenous treatment
Foot length (French unit)
Lower limb height (cm)
Ankle circumference, above malleoli (cm)
Maximal calf circumference (cm)
Phlebotropic treatment
NSAID
Analgesic treatment
Antithrombotic treatment
BMI, Body mass index; NSAID, nonsteroid anti-inflammatory drug; VCSS,
Data are median (interquartile range) or number (%).
aA modified version of the VCSS was used, stripped from its “compressive tsuccess was significantly higher in the progressive compres- iive stocking group (70.0%) than in the degressive com-
ressive stocking group (59.6%; risk-ratio 1.18; 95% CI,
.02-1.37; P  .03; Table II). This difference was mainly
xplained by a higher rate of symptom improvement in the
rogressive compressive stocking group. A subgroup anal-
sis showed that, for patients with C2b CEAP score, there
as a trend for a lesser efficacy of progressive compressive
tocking (Table III).
Secondary outcomes. Regarding the treatment effect
ver time, mainly evaluated through phone calls to the
atients, there was no significant difference in the success
ate at months 1 and 6 (Table II). Over the whole 6-month
tudy, thromboembolic events were recorded in five pa-
ients (2.6%) in the progressive compressive stocking group
nd six (3.1%) in the degressive compressive stocking
roup. No venous ulcer was reported.
The other secondary outcomes are shown in Table IV.
atients’ compliance was similar between the two groups,
ith no statistically significant difference at month 3: 72.2%
f the progressive compressive stocking group used the
reatment all day vs 71.1% in the degressive compressive
tocking group. Forty-two patients stopped compressive stock-
Progressive
ompressive stockings
(n  199)
Degressive
compressive stockings
(n  202)
53 (43-62) 54 (42-62)
54 (27.7%) 43 (21.7%)
38 (19.7%) 39 (19.9%)
32 (16.4%) 40 (20.2%)
128 (65.6%) 130 (65.7%)
23 (11.8%) 21 (10.6%)
8 (4.1%) 5 (2.5%)
4 (2.1%) 2 (1.0%)
5.0 (4.0-6.0) 4.0 (4.0-5.0)
154 (79.0%) 150 (75.8%)
80 75
57 57
17 18
46 (23.6%) 47 (23.7%)
25 26
27 29
11 9
124 (63.9%) 116 (58.6%)
107 101
55 58
39 (38-42) 39 (38-41)
40 (38-41) 40 (38-41)
23 (22-24) 23 (22-25)
38 (36-40) 38 (36-40)
55 (28.2%) 46 (23.2%)
9 (4.6%) 5 (2.5%)
22 (11.3%) 13 (6.6%)
14 (7.2%) 16 (8.1%)
us Clinical Severity Score; VTE, venous thromboembolism.
y” item.c
Venongtherapybeforemonth3:22 fromtheprogressivecompressive
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stocking group. The main reasons for stopping treatment
were discomfort or difficulty in applying the stockings (16
patients from each group). The study stockings were con-
sidered easy to apply for 86.2% of patients from the pro-
gressive compressive stocking group vs 57.1% of patients
from the degressive compressive stocking group up to 6
months (P  .0001). Stocking-related discomfort or harm
did not differ between groups. Venous insufficiency-related
treatments during the study are presented in Table V. Pre-
scriptions of phlebotropic or antithrombotic drugs did not
differ between groups, whereas nonsteroid anti-inflammatory
Table II. Composite success outcome
Progressi
compressi
stocking
(n  199
Composite success outcomea at month 3
(primary outcome) 132/188 (70
Failures
No improvement in pain or heavy legs 54/187b (28
Thromboembolic event 2/195c (1.0
Superficial vein thrombosis 0
Deep vein thrombosis 2
Pulmonary embolism 0
Venous ulcer 0
Composite success outcomea at month 1 99/163 (60
Failures
No improvement in pain or heavy legs 64/163 (39
Thromboembolic event 0/198
Superficial vein thrombosis
Deep vein thrombosis
Pulmonary embolism
Venous ulcer 0
Composite success outcomea at month 6 104/155 (67
Failures
No improvement in pain or heavy legs 46/152 (30
Thromboembolic eventd 5/189 (2.6
Superficial vein thrombosis 1
Deep vein thrombosis 4
Pulmonary embolism 0
Venous ulcer 0
CI, Confidence interval; RR, relative risk.
Data are n/N (%).
aDefined as an improvement in pain or heavy legs without onset of either u
bFor one patient in each group, pain and heavy legs were not recorded in tw
cFour patients from the progressive group and five patients from the degres
dOne patient may have experienced more than one event.
Table III. Composite success outcomea at month 3 (prim
Progressive com
stockings (n
Composite success outcome at month 3a
C2b 20/31 (6
C3 88/124 (7
C4a to C5 23/31 (7
CI, Confidence interval; RR, relative risk.
aDefined as an improvement in pain or heavy legs without onset of either udrugs and analgesic treatment were slightly more pre- gcribed, at month 6, in patients from the progressive com-
ressive stocking group.
Fifteen serious adverse events were reported: nine
4.5%) in the progressive compressive stocking group and
ix (3.0%) in the degressive compressive stocking group.
nly one of these was deemed possibly related to compres-
ive stocking treatment by the investigator: an uncompli-
ated varicose vein surgery in the progressive compressive
tocking group at the 6-month follow-up.
ISCUSSION
This superiority trial has demonstrated that these pro-
Degressive
compressive
stockings
(n  202) RR (95% CI) P value
115/193 (59.6%) 1.18 (1.02-1.37) .03
75/192b (39.1%)
4/197c (2.0%)
1
2
1
0
104/165 (63.0%) 0.96 (0.81-1.14) .67
60/164 (36.6%)
3/202 (1.5%)
1
1
1
0
120/164 (73.2%) 0.92 (0·79-1.06) .24
39/162 (24.1%)
6/193 (3.1%)
3
3
1
0
romboembolism.
ients (one from each group) who experienced a thromboembolic event.
oup were lost to follow-up before month 3.
utcome) according to baseline CEAP clinical score
sive
)
Degressive compressive
stockings (n  202) RR (95% CI)
) 28/36 (77.8%) 0.83 (0.61-1.14)
) 72/126 (57.1%) 1.24 (1.03-1.50)
) 14/28 (50.0%) 1.48 (0.97-2.27)
romboembolism.ve
ve
s
)
.2%)
.90%)
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.7%)
.3%)
.1%)
.3%)
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November 20121348 Couzan et almonths than usual degressive compressive stockings, im-
proving pain and lower leg symptoms in patients with CVI
while raising no safety concern. They were also easier to
apply.
This study was the first randomized controlled trial
including patients with moderate and severe venous insuf-
ficiency using selected criteria CEAP and assessing the
medium-term clinical benefit of a compressive stocking
treatment for patients in ambulatory settings.
The characteristics of the study population, including 66%
of patientswith edema (ie, class 3CEAP), correspond to those
found in the epidemiologic surveys,1,2 so results are transpos-
Table IV. Secondary outcomes
Progr
stock
Month 1
Compliance: stocking wearing
Never, occasionally, or rather regularly
Most of the time
From morning to bedtime 1
Stockings easy to apply 1
Discomfort wearing stockings
None or mild discomfort 1
Important discomfort
Stocking-related harm
At least one
Allergic symptoms
Itching
Constriction, tightness
Month 3
VCSSa
Compliance: stockings wearing
Never, occasionally, or rather regularly
Most of the time
From morning to bedtime 1
Stockings easy to apply 1
Discomfort wearing stockings
None or mild discomfort 1
Important discomfort
Stocking-related harm
At least one
Allergic symptoms
Itching
Constriction, tightness
Month 6
Compliance: stockings wearing
Never, occasionally, or rather regularly
Most of the time
From morning to bedtime 1
Stockings easy to apply 1
Discomfort wearing stockings
None or mild discomfort 1
Important discomfort
Stocking-related harm
At least one
Allergic symptoms
Itching
Constriction, tightness
VCSS, Venous Clinical Severity Score.
Data are mean (SD) for venous clinical severity score and number (%) other
aA modified version of the VCSS was used, stripped from its “compressive table to general population with symptomatic CVI. rChronic pain and heavy legs represent a significant
urden in the life of patients and treatment is required,
egardless of the CEAP score.
Because this is a newer progressive compressive stock-
ng concept and because the vast majority of compressive
tockings are prescribed for painful symptoms in ambula-
ory patients with CVI, the first clinical step was to show the
fficacy of progressive compressive stockings on these
ymptoms, after exclusion of patients with active ulcers who
equire specific compression treatments (ie, bandages). The
valuation of efficacy at 3 months was chosen because we
elieved that any clinical improvement should be seen in a
compressive
n  199)
Degressive compressive
stockings (n  202) P value
.35
.6%) 22 (10.9%)
.1%) 27 (13.4%)
1.2%) 153 (75.7%)
1.6%) 95 (47.7%) .0001
5.7%) 174 (86.6%) .81
4.3%) 27 (13.4%)
3.1%) 93 (47.0%) .44
1 1
7 20
3 82
.6) 3.1 (1.6) .60
3.9%) 25 (13.4%)
3.9%) 29 (15.5%)
2.2%) 133 (71.1%)
1.3%) 92 (49.7%) .0001
5.9%) 134 (72.4%) .44
4.1%) 51 (27.6%)
3.3%) 92 (49.5%) .23
0 0
8 22
7 78
.99
4.4%) 27 (14.4%)
1.1%) 21 (11.2%)
4.4%) 140 (74.5%)
6.2%) 108 (57.1%) .0001
9.4%) 173 (91.1%) .60
0.6%) 17 (8.9%)
9.2%) 96 (50.5%) .79
2 0
0 15
9 91
y” item.essive
ings (
19 (9
18 (9
60 (8
60 (8
68 (8
28 (1
84 (4
1
7
3.2 (1
26 (1
26 (1
35 (7
52 (8
42 (7
45 (2
81 (4
1
6
26 (1
20 (1
34 (7
56 (8
61 (8
19 (1
89 (4
2
7elatively short period of time and it corresponded to the
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Volume 56, Number 5 Couzan et al 1349typical time of the next appointment by the treating physi-
cian.
The blinded randomized comparator was a graded
degressive compressive stocking with 30 mm Hg pressure
at the ankle because it has the highest level of evidence and
because it is recommended for the treatment of CVI in all
CEAP classes, which was the targeted population in the
study.4 Whether this superiority is associated with a modi-
fication of venous hemodynamics is currently being inves-
tigated.
Fig 2 summarizes a meta-analysis of individual data
from a previous randomized, double-blind, controlled trial
of progressive compressive stockings in patients with mild
venous insufficiency10 and those reported here. The meta-
analysis suggests that a progressive compressive stocking is
more effective than a degressive compressive stocking in
improving symptoms of venous insufficiency (RR, 1.18;
CI, 1.04-1.33; P .01; Fig 2). The meta-analysis provides
more reliable estimates of the effects of this new concept of
progressive compressive stockings in venous insufficiency
among patients with mild, moderate, or severe venous
insufficiency.
The trend for a lesser efficacy of progressive compres-
sive stocking observed in patients with less severe venous
insufficiency (class C2b of CEAP; ie, patients without
edema) is not confirmed by the results of the Booster study
showing the superiority of the progressive compressive
stockings in patients with only mild venous insufficiency.10
The results for patients classified as C2b could be due to the
small sample size of this subgroup.
Progressive compressive stockings with higher pressure
at the calf than the ankle were considered easier to apply
(with a rate of 86% of patients in the progressive compres-
sive stocking group up to 6months compared to 57% in the
degressive compressive stocking group). The main expla-
Table V. Treatment for venous insufficiency
Progressive
compressive
stockings
(n  199)
Degressive
compressive
stockings
(n  202)
Month 1
Phlebotropic drug 50 (25.4%) 37 (18.3%)
NSAID 10 (5.1%) 5 (2.5%)
Analgesic treatment 20 (10.2%) 14 (7.0%)
Antithrombotic treatment 11 (5.6%) 16 (8.0%)
Month 3
Phlebotropic drug 33 (17.4%) 33 (17.6%)
NSAID 10 (5.3%) 7 (3.7%)
Analgesic treatment 22 (11.6%) 23 (12.2%)
Antithrombotic treatment 17 (8.9%) 19 (10.1%)
Month 6
Phlebotropic drug 41 (21.8%) 37 (19.2%)
NSAID 18 (9.6%) 7 (3.7%)
Analgesic treatment 31 (16.5%) 16 (8.3%)
Antithrombotic treatment 11 (5.9%) 15 (7.8%)
NSAID, Nonsteroid anti-inflammatory drug.
Data are numbers (%).nation is that the passage of the ankle is more difficult with oegressive stockings because the mean pressure at that level
s higher (30 mm Hg) than that of progressive stockings
10 mm Hg).
Even though easiness to apply was observed more
requently with progressive compressive stockings, we did
ot show a difference between treatment groups’ compli-
nce, indeed excellent in both groups. The good compli-
nce observed in both groups was likely due to the fact that,
n a clinical trial, investigators are encouraged to get the
est compliance from their patients. We believe that in real
ife, the compliance for wearing traditional stockings is less
han in our study.
Correlation between easiness to apply and compliance
ust be evaluated by surveys.
Whereas themost feared secondary effect of progressive
ompressive stockings was the tourniquet effect, as the
ighest pressure was applied at the calf below the knee,
olerance of the stockings was equal in the two groups with
dentical constriction or tight feeling. Moreover, there was
o increase and even a lower rate in superficial and deep
ein thrombosis.
The objective of compressive stocking therapy is to
rovide external compression to the leg and to oppose to
he hydrostatic forces of venous hypertension through the
ncrease of tissue pressure.13 The improvement of symp-
oms during CVI is thought to be linked to the improve-
ent of venous hypertension. As the calf muscle pump is
he major determinant of ambulatory pressure, we hypoth-
sized that applying the highest elastic pressure at the calf
ould decrease venous hypertension and be more efficient
n reducing symptoms in ambulatory settings.
The application of high textile pressure at the calf must
ntegrate the absorption coefficient of different tissues,
specially fat and muscle that influence the entire venous
ystem.14
The analysis of the behavior of biological tissues under
he effect of compression allows us to consider other studies
ncorporating these new settings.
This study has demonstrated that progressive compres-
ive stockings may improve pain and lower leg symptoms in
atients with CVI, the first reason of medical consultation.
oreover, progressive compressive stockings were easier to
pply, while raising no safety concern at 3 months. Further
nvestigations are needed for the evaluation of progressive
ompressive stockings on maintenance of effect in improv-
ng venous insufficiency symptoms and on longer-term
omplications such as ulcers and deep vein thrombosis.
ONTRIBUTORS
Coordinating center: E. Gauthier, M. Hervé, A. Leizo-
ovicz (Director), A. Merah, M. Pereira.
Logistic center for treatment distribution: Inserm,
IE3, F- 42055 Saint-Étienne, France (Mrs C. Chauvet,
. Bernabé).
Laboratoire Pierre Fabre, France, approved the study
rotocol, provided the stockings, gave an unrestricted
rant for the conduct of the study, and was given the
pportunity to comment on the manuscript.
11
1
1
1
S
JOURNAL OF VASCULAR SURGERY
November 20121350 Couzan et alAUTHOR CONTRIBUTIONS
Conception and design: AL, SC, JP, PM, SL
Analysis and interpretation: AL, SC, JP, IQ, CC, SL
Data collection: SC
Writing the article: AL, SC, JP, IQ
Critical revision of the article: AL, SC, PM, IQ, SL, CC
Final approval of the article: AL, SC, JP, PM, IQ, CC, SL
Statistical analysis: CC, SL
Obtained funding: SC, JP
Overall responsibility: SC
REFERENCES
1. Preziosi P, Galan P, Aissa M, Hercberg S, Boccalon H. Prevalence of
venous insufficiency in French adults of the SUVIMAX cohort.
SUpplémentation en VItamines et Minéraux AntioXydants. Int Angiol
1999;18:171-5.
2. Bradbury A, Evans C, Allan P, Lee A, Ruckley CV, Fowkes FG.What are
the symptoms of varicose veins? Edinburgh vein study cross sectional
population survey. BMJ 1999;318:353-6.
3. Motykie GD, Caprini JA, Arcelus JI, Reyna JJ, Overom E, Mokhtee D.
Evaluation of therapeutic compression stockings in the treatment of
chronic venous insufficiency. Dermatol Surg 1999;25:116-20.
4. Rabe E, Partsch H, Jünger M, Abel M, Achhammer I, Becker F, et al.
Guidelines for clinical studies with compression devices in patients with
venous disorders of the lower limb. Eur J Vasc Endovasc Surg 2008;35:
494-500.
5. Nicolaides AN, Allegra C, Bergan J, Bradbury A, Cairols M, Carpentier
Study
Progressive
compressive 
stockings
Degressive
compressive 
stockings
BOOSTER 10 46 / 63 40 / 64
Present study             132 / 188 115 / 193
Overall
De
(Heterogeneity test: p = 0.94)
Fig 2. Meta-analysis comparing progressive compressi
success rate. A relative risk (RR) greater than 1 means a
lower than 1 means a worse efficacy, and an RR means a
interval (CI) does not cross the value 1.P, et al. Management of chronic venous disorders of the lower limbs:
guidelines according to scientific evidence. Int Angiol 2008;27:1-59. a6. Raju S, Hollis K, Neglen P. Use of compression stockings in chronic
venous disease: patient compliance and efficacy. Ann Vasc Surg 2007;
21:790-5.
7. Mosti G, Partsch H. Compression stockings with a negative pressure
gradient have a more pronounced effect on venous pumping function
than graduated elastic compression stockings. Eur J Vasc Endovasc Surg
2011;42:261-6.
8. Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner
RL, et al. Revision of the CEAP classification for chronic venous
disorders: consensus statement. J Vasc Surg 2004;40:1248-52.
9. Rutherford RB, Padberg FT Jr, Comerota AJ, Kistner RL, Meissner
MH, Moneta GL. Venous severity scoring: an adjunct to venous out-
come assessment. J Vasc Surg 2000;31:1307-12.
0. Couzan S, Assante C, Laporte S,Mismetti P, Pouget JF. [Booster study:
comparative evaluation of a new concept of elastic stockings in mild
venous insufficiency]. [Article in French] Presse Med 2009;38:355-61.
1. CucheratM, Boissel JP, Leizorovicz A,HaughMC. EasyMa: a program
for the meta-analysis of clinical trials. Comput Methods Programs
Biomed 1997;53:187-90.
2. EasyMa.net. Available at: http://www.spc.univ-lyon1.fr/easyma.net.
Accessed November 21, 2006.
3. Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation
2005;111:2398-409.
4. Avril S, Bouten L, Dubuis L, Drapier S, Pouget JF. Mixed experimental
and numerical approach for characterizing the biomechanical response
of the human leg under elastic compression. J Biomech Eng 2010;132:
031006.
ubmitted Jan 6, 2012; accepted Feb 26, 2012.
Additional material for this article may be found online
1.17 [0.92; 1.49] 
1.18 [1.02; 1.37] 
1.18 [1.04; 1.33] 
1.0 1.1 1.2 1.3 1.4
RR [95% CI] 
p=0.01
ive
r
Progressive 
better
ckings with degressive compressive stockings on the
r efficacy with progressive compressive stockings, an RR
of difference. The result is significant if the confidence0.9
gress
bette
ve sto
bette
lackt www.jvascsurg.org.
S
T
P
B
G
V
M
S
D
C
G
T
JOURNAL OF VASCULAR SURGERY
Volume 56, Number 5 Couzan et al 1350.e1APPENDIX (online only). Contributing investigators
to this study
Serge Couzan, Saint-Etienne; Aude Agache, Vienne;
Dominique Brisot, Clapiers; François Bucci, Grenoble;
Richard Cayman, Bourgoin-Jailleu; Jean-Luc Daussin,
Strasbourg; Jean-Louis Domenger, Gueret; Christian
Frenchinos, Malemort; Christophe Galland, Chenove;
Jean-Luc Gillet, Bourgoin-Jailleu; Jean-Pierre Gobin,
Lyon; Catherine Grossetete, Lyon; Catherine Grunewald,
La Madeleine; Nathalie Guilhem-Cantala, Colomiers; Béa-
trice Hagemann, Dijon; Christine Leandri, Annonay; Lau-
rent Marcy, Meaux; Caroline Poulain, Montelimar; Corinne
Poulain-Veyre, Vienne; Bruno Rouqet, Montelimar; Eliane Fimonot, Cambrai; Christine Stirnemann, Saverne; Gérard
ardy, Pontoise; Anne Vine, Toulouse; Chi-Tam Vuong,
ontoise; Charles Zarca, Annemasse; Dominique Riviere,
eauvais; Alexandra Buffler, Saverne; Jean-Marc Diamand,
renoble; Pascal Goffette, Dole; Charles-Maxime Nedey,
illeurbanne; Georges Eyre, Montelimar; Roselyne Garden,
ontelimar; Laurence Janteur-Gonzalez, Ermont; Anne-
ophie Debuse, Lille; Christine Jurus, Villeurbanne; Serge
uest, Annemasse; Anne Tissot, Villeurbanne; Frédérique
arrie, Toulouse; Anne Sophie Boved, Toulouse; Michèle
iraud, Toulouse; Marie-Françoise Fauroux-Galinier,
oulouse; Cathi Schmitt-Roger, Strasbourg; Jean-Luc
rey, Schiltigheim.
